Medicare Enrolled
Dr. Lawrence Saltis, MD
Neurology · Akron, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saltis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saltis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saltis
Dr. Lawrence Saltis is a neurology specialist in Akron, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Saltis performed 12,811 Medicare services across 618 unique beneficiaries.
Between the years covered by Open Payments, Dr. Saltis received a total of $32,552 from 101 pharmaceutical and/or device companies across 1899 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saltis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in OH
$32,552 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,811
Medicare services
Top 5% in OH for neurology
618
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~641 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Ocrelizumab infusion (Ocrevus) for MS | 12,000 | $45 | $135 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
115 | $110 | $412 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
111 | $72 | $226 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
92 | $93 | $316 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
68 | $47 | $177 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
66 | $63 | $223 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
47 | $21 | $73 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
41 | $150 | $557 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $135 | $495 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
34 | $4 | $25 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
32 | $86 | $312 |
| EEG brain wave test, 61-119 minutes This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes. |
27 | $310 | $1,221 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
27 | $93 | $335 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
26 | $11 | $53 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
22 | $61 | $189 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
20 | $318 | $1,170 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
19 | $71 | $257 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
12 | $81 | $327 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
11 | $282 | $972 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
94.4% high complexity
1.3% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$32,552
Total received (2018-2024)
Avg $4,650/year across 7 years
Top 16% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
101
Companies
1,899
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$32,191 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$361 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,099
2023
$5,463
2022
$5,362
2021
$5,077
2020
$2,858
2019
$2,734
2018
$3,958
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$544
Novartis Pharmaceuticals Corporation
$488
Inspire Medical Systems, Inc.
$450
ABBVIE INC.
$395
Alexion Pharmaceuticals, Inc.
$356
HARMONY BIOSCIENCES LLC
$303
GENZYME CORPORATION
$276
Genentech USA, Inc.
$270
Lilly USA, LLC
$263
Eisai Inc.
$253
SK Life Science, Inc.
$252
Neurocrine Biosciences, Inc.
$245
Teva Pharmaceuticals USA, Inc.
$243
EMD Serono, Inc.
$215
ACADIA Pharmaceuticals Inc
$214
ARGENX US, INC.
$213
JAZZ PHARMACEUTICALS INC.
$189
Vanda Pharmaceuticals Inc.
$185
Mallinckrodt Hospital Products Inc.
$182
TG Therapeutics, Inc.
$172
Celgene Corporation
$154
PFIZER INC.
$152
Axsome Therapeutics, Inc.
$133
Biogen, Inc.
$132
Lundbeck LLC
$106
Takeda Pharmaceuticals U.S.A., Inc.
$89
Avadel CNS Pharmaceuticals, LLC
$80
Harmony Biosciences Llc
$73
Octapharma USA, Inc.
$67
Grifols USA, LLC
$65
Amgen Inc.
$49
Otsuka America Pharmaceutical, Inc.
$49
Sandoz Inc.
$49
MITSUBISHI TANABE PHARMA AMERICA, INC.
$43
Neurelis, Inc.
$35
Azurity Pharmaceuticals, Inc.
$29
Kedrion Biopharma, Inc.
$19
Cycle Pharmaceuticals Inc
$19
Xeris Pharmaceuticals, Inc.
$19
SCILEX PHARMACEUTICALS INC.
$16
Nevro Corp.
$13
Top 3 companies account for 20.9% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$2,122
Alexion Pharmaceuticals, Inc.
$1,874
Novartis Pharmaceuticals Corporation
$1,659
Teva Pharmaceuticals USA, Inc.
$1,582
UCB, Inc.
$1,522
GENZYME CORPORATION
$1,369
Amgen Inc.
$1,258
EMD Serono, Inc.
$1,226
Inspire Medical Systems, Inc.
$1,112
SK Life Science, Inc.
$1,096
Lundbeck LLC
$1,021
Neurocrine Biosciences, Inc.
$878
JAZZ PHARMACEUTICALS INC.
$847
Eisai Inc.
$790
Genentech USA, Inc.
$789
AbbVie Inc.
$731
ABBVIE INC.
$723
ACADIA Pharmaceuticals Inc
$677
Celgene Corporation
$573
Harmony Biosciences LLC
$515
Lilly USA, LLC
$465
Sunovion Pharmaceuticals Inc.
$431
HARMONY BIOSCIENCES LLC
$371
Axsome Therapeutics, Inc.
$370
PFIZER INC.
$361
EISAI INC.
$354
ARGENX US, INC.
$340
Mallinckrodt Hospital Products Inc.
$325
Biohaven Pharmaceuticals, Inc.
$306
Grifols USA, LLC
$298
Avanir Pharmaceuticals, Inc.
$285
Avion Pharmaceuticals
$283
Neurelis, Inc.
$247
Kyowa Kirin, Inc.
$244
Janssen Pharmaceuticals, Inc
$242
CSL Behring
$240
Takeda Pharmaceuticals U.S.A., Inc.
$231
Greenwich Biosciences, Inc.
$219
Supernus Pharmaceuticals, Inc.
$216
TG THERAPEUTICS, INC.
$204
Horizon Therapeutics plc
$195
Jazz Pharmaceuticals Inc.
$187
Vanda Pharmaceuticals Inc.
$185
Biohaven Pharmaceutical Holding Company Ltd.
$178
TG Therapeutics, Inc.
$172
Mallinckrodt LLC
$171
Allergan, Inc.
$146
E.R. Squibb & Sons, L.L.C.
$126
Xeris Pharmaceuticals, Inc.
$118
Acorda Therapeutics, Inc
$109
Adamas Pharmaceuticals, Inc.
$106
Genentech, Inc.
$106
Avadel CNS Pharmaceuticals, LLC
$98
Strongbridge US INC.
$98
Merz North America, Inc.
$95
MITSUBISHI TANABE PHARMA AMERICA, INC.
$92
Bayer HealthCare Pharmaceuticals Inc.
$90
Sumitomo Pharma America, Inc.
$88
PORTOLA PHARMACEUTICALS, LLC
$82
US WorldMeds, LLC
$80
Averitas Pharma Inc.
$73
IDORSIA PHARMACEUTICALS US INC
$73
Otsuka America Pharmaceutical, Inc.
$73
Harmony Biosciences Llc
$73
AstraZeneca Pharmaceuticals LP
$72
ARBOR PHARMACEUTICALS, INC.
$72
CATALYST PHARMACEUTICALS, INC.
$67
Octapharma USA, Inc.
$67
LivaNova USA, Inc.
$67
Bausch Health US, LLC
$65
Merck Sharp & Dohme Corporation
$64
Impax Laboratories, Inc.
$59
Smith+Nephew, Inc.
$56
Abbott Laboratories
$51
GE HealthCare
$51
Catalyst Pharmaceuticals, Inc.
$51
Sandoz Inc.
$49
Azurity Pharmaceuticals, Inc.
$43
Almatica Pharma LLC
$42
NOBELPHARMA AMERICA, LLC
$40
Nevro Corp.
$37
Mitsubishi Tanabe Pharma America, Inc.
$32
Merck Sharp & Dohme LLC
$29
Zyla Life Sciences
$28
Vertical Pharmaceuticals, LLC
$27
BANNER LIFE SCIENCES, LLC
$26
Banner Life Sciences, LLC
$24
Scilex Pharmaceuticals Inc.
$20
Ironshore Pharmaceuticals Inc.
$20
Kedrion Biopharma, Inc.
$19
Cycle Pharmaceuticals Inc
$19
AQUESTIVE THERAPEUTICS, INC.
$18
GE HEALTHCARE
$17
SCILEX PHARMACEUTICALS INC.
$16
Collegium Pharmaceutical, Inc.
$16
Saol Therapeutics Inc.
$15
Acerta Pharma LLC
$14
Promius Pharma LLC
$13
Medtronic Vascular, Inc.
$12
Arbor Pharmaceuticals, Inc.
$11
Egalet US Inc
$11
Top 3 companies account for 17.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · Andexxa · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BRILINTA · BRIUMVI · Betaseron · Briviact · COPAXONE · Dhivy · Dysport · ELIQUIS · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Evrysdi · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GAMMAGARD LIQUID · GILENYA · GOCOVRI · GRALISE · GVOKE PFS · Gamunex-C · HORIZANT · HYFTOR · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · Infinity DBS Pulse Generators · Inspire Upper Airway Stimulation System · Jornay PM 20mg capsules (Bottle of 100) · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · PONVORY · Ponvory · Privigen · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · REDAPT · REXULTI · RYTARY · Radicava · Rebif · Reveal LINQ · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Senza · Soliris · Sunosi · TECFIDERA · TROKENDI XR · TYSABRI · Tascenso ODT · UBRELVY · ULTOMIRIS · UPLIZNA · Ultomiris · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · XEOMIN · XYREM · XYWAV · Xadago · Xyrem · ZEPOSIA · ZINBRYTA · ZTLido · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
49
Per 100K population
9.1
County median income
$71,016
Nearest hospital
AKRON GENERAL MEDICAL CENTER
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saltis is a mixed practice specialist, with above-average Medicare volume (top 5% in OH), with low-engagement industry engagement in the top 16% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saltis experienced with ocrelizumab infusion (ocrevus) for ms?
Based on Medicare claims data, Dr. Saltis performed 12,000 ocrelizumab infusion (ocrevus) for ms services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saltis receive payments from pharmaceutical companies?
Yes. Dr. Saltis received a total of $32,552 from 101 companies across 1,899 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saltis's costs compare to other neurologists in Akron?
Dr. Saltis's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saltis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Akron
Browse neurologists in Akron ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in OH
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in OH
Which OH neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology